Literature DB >> 4825235

Release of adenosine from human hearts during angina induced by rapid atrial pacing.

A C Fox, G E Reed, E Glassman, A J Kaltman, B B Silk.   

Abstract

This study was designed to determine whether human hearts release adenosine, a possible regulator of coronary flow, during temporary myocardial ischemia and, if so, to examine the mechanisms involved. Release of adenosine from canine hearts had been reported during reactive hyperemia following brief coronary occlusion, and we initially confirmed this observation in six dogs hearts. Angina was then produced in 15 patients with anginal syndrome and severe coronary atherosclerosis by rapid atrial pacing during diagnostic studies. In 13 of these patients, adenosine appeared in coronary sinus blood, at a mean level of 40 nmol/100 ml blood (SE = +/-9). In 11 of these 13, adenosine was not detectable in control or recovery samples; when measured, there was concomitant production of lactate and minimal leakage of K(+), but no significant release of creatine phosphokinase, lactic acid dehydrogenase, creatine, or Na(+). THERE WAS NO DETECTABLE RELEASE OF ADENOSINE BY HEARTS DURING PACING OR EXERCISE IN THREE CONTROL GROUPS OF PATIENTS: nine with anginal syndrome and severe coronary atherosclerosis who did not develop angina or produce lactate during rapid pacing, five with normal coronaries and no myocardial disease, and three with normal coronaries but with left ventricular failure. The results indicate that human hearts release significant amounts of adenosine during severe regional myocardial ischemia and anaerobic metabolism. Adenosine release might provide a useful supplementary index of the early effects of ischemia on myocardial metabolism, and might influence regional coronary flow during or after angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4825235      PMCID: PMC302633          DOI: 10.1172/JCI107693

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Enzymatic determination of creatine in serum and cerebrospinal fluid.

Authors:  H H Berlet
Journal:  Clin Chim Acta       Date:  1968-04       Impact factor: 3.786

2.  Haemodynamic effects of dipyridamole at rest and during exercise in healthy subjects.

Authors:  G A Bousvaros; J E Campbell; M McGregor
Journal:  Br Heart J       Date:  1966-05

3.  Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance.

Authors:  R Rubio; R M Berne
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

4.  Certain clinical characteristics correlated with extent of obstructive lesions demonstrated by selective cine-coronary arteriography.

Authors:  W L Proudfit; E K Shirey; W C Sheldon; F M Sones
Journal:  Circulation       Date:  1968-11       Impact factor: 29.690

5.  Changes in content of purine nucleoside in canine myocardium during coronary occlusion.

Authors:  R A Olsson
Journal:  Circ Res       Date:  1970-03       Impact factor: 17.367

6.  The effect of ischemia and alterations of heart rate on myocardial potassium balance in man.

Authors:  J O Parker; M A Chiong; R O West; R B Case
Journal:  Circulation       Date:  1970-08       Impact factor: 29.690

7.  Release of adenosine in reactive hyperemia of the dog heart.

Authors:  R Rubio; R M Berne; M Katori
Journal:  Am J Physiol       Date:  1969-01

8.  Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.

Authors:  E P Marbach; M H Weil
Journal:  Clin Chem       Date:  1967-04       Impact factor: 8.327

9.  Adenylate deaminase. 3. Regulation of deamination pathways in extracts of rat heart and lung.

Authors:  R Burger; J M Lowenstein
Journal:  J Biol Chem       Date:  1967-11-25       Impact factor: 5.157

10.  An electrocardiographic, anatomic, and metabolic study of zonal myocardial ischemia in coronary heart disease.

Authors:  M V Herman; W C Elliott; R Gorlin
Journal:  Circulation       Date:  1967-05       Impact factor: 29.690

View more
  21 in total

1.  [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].

Authors:  M Böhm
Journal:  Klin Wochenschr       Date:  1987-06-01

2.  Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.

Authors:  M Ungerer; M Böhm; R H Schwinger; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  Stress signaling by Tec tyrosine kinase in the ischemic myocardium.

Authors:  Michael J Zhang; Sarah Franklin; Yifeng Li; Sujing Wang; Xiaochen Ru; Scherise A Mitchell-Jordan; Hiroyuki Mano; Enrico Stefani; Peipei Ping; Thomas M Vondriska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

Review 4.  Cellular and molecular mechanism(s) of coronary flow regulation by adenosine.

Authors:  S J Mustafa
Journal:  Mol Cell Biochem       Date:  1980-06-18       Impact factor: 3.396

5.  Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Authors:  M Böhm; R Brückner; W Meyer; M Nose; W Schmitz; H Scholz; J Starbatty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Inotropic response to DPI 201-106 in the failing human heart.

Authors:  M Böhm; F Diet; B Kemkes; M Wankerl; E Erdmann
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Studies of the nucleoside transporter inhibitor, draflazine, in the human myocardium.

Authors:  M Böhm; C Weinhold; R H Schwinger; J Müller-Ehmsen; D Böhm; H Reichenspurner; B Reichart; E Erdmann
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium.

Authors:  L Belardinelli; E C Mattos; R M Berne
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Evidence against the adenosine-catecholamine antagonism under in vivo conditions.

Authors:  R Seitelberger; W Schütz; O Schlappack; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

10.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Authors:  B N Cronstein; R I Levin; J Belanoff; G Weissmann; R Hirschhorn
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.